The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

Wellness coach Rachael Sacerdoti shares her advice for women in midlife coming off Ozempic, Mounjaro and other weight loss ...

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

The drug is still going through trials, but the medical company Lilly, behind it, is hopeful it can be rolled out soon. In ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.